Chapter 44: Hematologic Disorders in Children Nursing Care

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Welcome back to The Deep Dive, the place where we turn dense, critical knowledge like an entire chapter on pediatric hematologic disorders into the clear, actionable insights you need.

Hey, glad to be here.

Our mission today is pretty laser focused.

We're synthesizing the core of this material for nursing students.

We want to move beyond just describing normal growth.

Right, and really get into understanding the dramatic physical and psychosocial changes that happen when a child is living with a chronic blood disorder.

It's a deep dive into what are called blood dyscrasias.

Which is really just an alteration in the formed elements of the blood.

So your RBCs, WBCs, platelets, and these are vital functions.

Transporting oxygen, removing waste, making sure you can clot.

And when they fail.

The impact on a growing child is profound.

It's often multi -systemic.

So we have to, you know, synthesize the complex biochemistry with the long -term realities of family life and just adherence to treatment.

Let's immediately anchor this in clinical reality.

I think it's helpful to remember the two patients we meet in the source material.

These vignettes really capture the chronic,

visible impact of these diseases.

Yeah, they do.

First, you have the four -year -old with thalassemia major.

And when you look at this child, you literally see the disease.

A prominent mandible, the maxilla bossing.

And wide spaced upper front teeth.

These are visible markers of a desperate lifelong fight really.

It's caused by the bone marrow overgrowing its normal confines because it's trying so hard to produce more cells.

And then there's the seven -year -old with sickle cell anemia.

And his growth is stunted.

He's only in the fifth percentile for his age.

And he has this constant threat of pain just hanging over him.

He's had two severe vaso -occlusive crises in the past year alone.

These scenarios, they always lead to the same fundamental questions from parents, which really drive our learning today.

They always do.

It's why did this happen?

And what is the true measure of a good life for our child given this chronic condition?

So our goal is to prepare you to provide not just the medical answers, but really compassionate evidence -based care.

And a huge part of that compassionate care starts with cultural awareness because these are often inherited disorders and they have very specific distribution patterns.

That's a critical starting point.

It really is.

Sickle cell anemia is significantly prevalent in black people, while thalassemia is primarily associated with individuals of Mediterranean descent.

So nurses have to be aware of these inherited patterns for genetic counseling, for early screening.

And then there's the treatment itself.

Right.

Since treatment for so many of these disorders involves blood products, we have to always respect religious and cultural values.

You know, you have to note the specific challenge presented by Jehovah's Witnesses, whose beliefs might preclude life -saving blood transfusions.

So the nurse has to be ready with and supportive care.

Absolutely.

So let's lay out the roadmap.

We're starting with the foundational anatomy and physiology, but we're only going to focus on the parts that are clinically actionable.

Then we'll move into the core of nursing practice, the nursing process, critical therapeutic techniques, and finally a methodical breakdown of the major disorders of red blood cells and coagulation.

Let's unpack it.

Okay.

Starting with the life cycle of blood,

the system is pretty elegant.

Components are formed in the bone marrow.

They're circulated and then destroyed, mostly by the spleen.

It completes the loop.

Before we even look at the components, there's a really vital developmental concept here, blood volume.

Yes.

And while the specific numbers, you know, the milliliters per kilogram, they change rapidly in the first year of life.

High at birth, then it drops, then stabilizes.

Right.

The principle is what matters for the nurse.

Infants and young reservoir relative to their size, which makes any acute loss a much bigger deal, a far more immediate and critical threat than it would be in an adult.

So your fluid and blood replacement calculations have to be precise.

Even small volume shifts are incredibly dangerous.

And while something like dehydration focuses on plasma,

pediatric hematologic disorders focus squarely on the formed elements.

Exactly.

We're concentrating on the erythrocytes, RBCs, leukocytes, WBCs and thrombocytes platelets.

These are the parts that fail when a child has a blood dyscrasia.

Let's dive into RBCs.

What drives the production of these crucial oxygen transporters?

And what's the key clinical takeaway from that mechanism?

Okay.

So RBCs are all about oxygen transport.

They're formed in the bone marrow, stimulated by the hormone erythropoietin.

Okay.

Now here's where we get to the actionable insight.

Erythropoietin is produced by the kidneys in response to tissue hypoxia, low oxygen.

So if you have a child with chronic kidney disease, you must immediately anticipate that they will have chronic anemia.

The kidneys can't produce enough erythropoietin to stimulate the bone marrow and it doesn't matter if the bone marrow itself is perfectly healthy.

And developmentally, the RBC count itself isn't stable.

It's high at birth and then it naturally dips.

That's the physiological nadir.

The count is high at birth, but it drops rapidly hitting a low point around three to four months of age before it slowly rises toward adult values.

That's an important piece of context, but you're saying the major shift happens within the cells and the hemoglobin.

Exactly.

Now when we're assessing how the marrow is responding, we don't need to memorize every single cell stage, but there's one critical marker we need,

the reticulocyte.

That's the key.

The maturation sequence is erythroblast to normal blast to reticulocyte.

And finally, the mature erythrocyte.

The reticulocyte is the immature RBC.

So if you see a high count.

An elevated reticulocyte count, anything above 1%, that is the bone marrow just screaming, I am trying desperately to catch up.

It signifies rapid production, usually in response to a major loss or destruction.

And a mature RBC lives for about 120 days.

Right.

This brings us to the structure of hemoglobin, HgB, the globin protein, and the heme iron pigment.

But the blood diseases is that shift from fetal to adult HgB.

This developmental shift is maybe the single most important concept in the entire chapter for understanding when diseases actually show up.

Okay.

Break that down for us.

Fetal HgB or HgBf has two alpha and two gamma chains.

At birth, it makes up say 40 to 70 % of the child's HgB.

The adult form HgBa replaces those gamma chains with two beta chains.

And this replacement process takes about six months.

Exactly.

And this is the crucial clinical link.

Disorders that rely on a defective beta chain like sickle cell anemia and thalassemia, they don't become clinically symptomatic until this six -month mark.

So our seven -year -old with SCA, his disease was silent for months.

Totally silent.

It was amassed by the protection of HgBf until the switch to HgBa made that beta chain defect apparent.

Once that 120 -day lifespan is over, the RBC is destroyed.

This leads to iron reuse and bilirubin metabolism.

And this is where a newborn's immature system is particularly vulnerable.

Yeah.

When the heme is degraded, it forms indirect bilirubin.

This is fat -soluble, which means the kidneys can't excrete it.

The liver has to convert it to water -soluble, direct bilirubin using the enzyme glucurinyl transphrase.

And in a newborn, that enzyme function is often immature.

Right.

Which means indirect bilirubin levels can rise quickly.

If they exceed seven milligrams per 100mL, that bilirubin permeates the tissues and you get jaundice.

It really highlights the delicate balance of a newborn system.

It does.

You have to monitor for signs that the destruction rate is just outpacing the liver's ability to excrete the waste product.

Okay.

Moving beyond RBCs, WBCs and platelets.

Leukocytes are far fewer and they're mainly focused on defense.

The major concern in hematology is neutropenia to few neutrophils, which puts the child at an extreme risk for infection.

And platelets?

Thrombocytes, or platelets, are non -nucleated cells vital for coagulation.

We're aiming for a count of 150 ,000 to 300 ,000 per cubic millimeter.

What if we see megakaryocytes?

If we see large numbers of megakaryocytes, the precursor cells, it tells us the bone marrow is reacting to a low platelet count and is actively trying to ramp up production.

Okay.

So now let's simplify the blood coagulation cascade.

We don't need to list every single factor, but we have to understand the process and where things can go wrong.

The chapter breaks it into four key stages.

Right.

Stage one is the immediate response.

The vessel constricts and the platelets rush to the injury site.

They adhere to the wall and to each other to form that initial plug.

Stage two is where things really come together.

It's the critical convergence.

You have factors from the plasma, the intrinsic pathway, and factors from the injured tissue, the extrinsic pathway.

They combine with platelet phospholipids to form complete thromboplastin.

And stage three requires two essentials.

What are they?

Thromboplastin converts prothrombin, which is factor two, into thrombin.

This step absolutely requires vitamin K and ionized calcium.

So if a child is deficient in vitamin K?

The conversion stalls.

The body just can't form a stable clot.

Finally, stage four is the permanent seal.

Thrombin converts fibrinogen, factor Y, into insoluble fibrin.

This is the strong mesh that incorporates all the cells and provides that permanent protective seal.

And of course, there's a control mechanism, plasmin, which breaks down the clot once the vessel wall has healed.

This complex system means we need specific tests to check the intrinsic and extrinsic pathways separately.

These diagnostic tests are essential knowledge.

Oh, absolutely.

The prothrombin time, or PT, assesses the extrinsic system and factors V, 7, and X.

And the PTT.

The partial thromboplastin time, PTT,

assesses the intrinsic system.

It reveals deficiencies in factors 8 through 12.

That's the system that fails in hemophilia A.

Then you have other tests like bleeding time and the tourniquet test, which primarily look at platelet function and capillary fragility.

Before we move on, we should briefly summarize the Healthy People 2030 goals as these national objectives directly inform pediatric nursing care.

Yeah, these goals really highlight our primary targets for improvement.

They aim to reduce the incidence of iron deficiency in two really vulnerable groups.

Young children, 1 to 4 years, and adolescents, 12 to 18 years.

They also focus on the physical toll of the chronic illness.

Right, specifically by decreasing the proportion of people with hemophilia who develop reduced joint mobility.

And this is directly related to our case study.

Reducing hospitalization due to preventable sickle cell complications in children under 9.

Which really emphasizes the nurse's role in prevention and education.

The goals ultimately point us toward increasing the proportion of children with special health care needs who have access to a medical home.

So our role is active education.

Active education on iron sources during pregnancy and childhood, promoting healthy diets and adolescents, and ensuring consistent preventative care and immunization schedules for children with disorders like sickle cell.

Okay, let's pivot from the what to the how applying the nursing process.

Starting with assessment.

The chapter stresses that many symptoms have an insidious onset.

Why is that so critical for the nurse?

It means the condition is creeping up slowly and it often delays diagnosis.

You know, pallor, fatigue, or mild bruising might be dismissed by busy parents as just normal childhood tiredness.

So you have to be meticulous in your history taking.

Meticulous.

Take iron deficiency.

The child might otherwise look fine.

Maybe even appear slightly obese in infancy because of all the milk they drink.

But the underlying issue is missed until we really dig deep into that history.

So let's detail that comprehensive assessment.

What are the key history points we need to pull out?

We need to ask specifically about chronic fatigue, easy bruising, recurrent epistaxis nosebleeds, and nutritional history.

And for infants.

Was there a low birth weight?

Did they get vitamin K at birth?

For older children, questions about pica craving inedible materials like dirt or ice, or being a picky eater who drinks excessive amounts of milk, say more than 32 ounces a day.

That is diagnostic gold.

And always the family history.

Always.

A thorough family history of inherited treats like thalassemia or hemophilia.

The physical exam provides clues that tie directly back to the underlying pathology.

Let's review those key findings.

General appearance.

Fatigue is universal in anemia.

But let's get specific.

Face and mouth.

Pale mucous membranes confirm anemia.

But remember our four -year -old with thalassemia.

The bossing of the maxillary bone.

That's a direct physical manifestation of the bone marrow's compensatory overgrowth.

Bleeding gums, on the other hand, signal a coagulation or platelet problem.

What about the heart and skin?

The heart races tachycardia and often develops a murmur because it's frantically trying to pump that reduced oxygen -carrying blood volume.

And skin findings are a roadmap.

A roadmap.

How so?

Patechiae, which are pinpoint and ecchymosis bruising.

They point to decreased coagulation.

Jaundice suggests increased RBC destruction, a hemolytic anemia.

Pallor signals anemia.

But a bronze color, hemosiderosis, that tells us the child has received frequent blood transfusions leading to iron deposition.

And finally, the extremities and neurological signs.

Spoon -shaped nails, or koelinicchia, are a classic sign of iron deficiency.

Joint swelling and pain are hallmarks of bleeding into the joint's hemarthrosis from hemophilia or vaso -occlusion from sickle cell disease.

Weak muscle tone might also be noted in iron deficiency due to the lack of iron -dependent enzymes.

Moving to nursing diagnosis.

Since so many of these are inherited, the psychosocial fallout on the family has to be addressed immediately.

That is often the first non -medical hurdle.

Families frequently internalize guilt or blame regarding an inherited disorder, which just strains the unit and hampers their ability to support the child.

So we have to create diagnoses that address this.

Beyond the obvious pain from tissue ischemia and malnutrition risk from a dietary pattern, we have to address knowledge deficiency about the cause of the illness,

anxiety from frequent blood sampling, and critically impaired family coping because of the chronic nature of it all.

Outcome identification and planning must be realistic, especially when it comes to adherence and managing procedures.

Exactly.

The goal isn't always to eliminate the stressor, but to minimize the trauma.

If we can't reduce the frequency of blood sampling, our plan shifts to reducing the associated fear and pain using developmentally appropriate distraction or complementary therapies.

Adherence is a massive long -term challenge, particularly for chronic diseases that don't always cause acute symptoms.

It's so hard.

It's easy for parents to be vigilant during a crisis, but maintaining that consistency for years, especially when the child feels fine, is tough.

So planning has to include practical strategies.

Yeah, like how to disguise the bad taste of an oral medication, or establishing a system to ensure nightly adherence to, say, an iron -chelating regimen.

We also have to plan for the child's developmental well -being, ensuring that activity restrictions, if they're required for immune compromise, don't socially isolate them from their peers.

Moving to implementation, let's talk about managing procedure pain.

Okay, you have to remember that for a small child, even a fingertip puncture can be a terrifying and painful event.

We need to be proactive.

So using anesthetic cream.

Use anesthetic cream like lidocaine prilocaine before any puncture.

If possible, consolidate blood draws using intermittent devices.

And crucially,

therapeutic or medical play letting the child use the syringes or bandages on a doll helps them externalize their fear and regain a sense of control over procedures done to them.

And finally, outcome evaluation.

This focuses on assessing both immediate relief and long -term adaptation.

Exactly.

We look for short -term success.

Is the pain moderated?

Is anxiety reduced during procedures?

But long -term, we look for functional success.

Are the parents accurately educating others about the child's illness?

Is the family coping?

Is the child adherent to medication?

And for our sickle cell patient?

Are the parents actively voicing their understanding of the absolute necessity of preventing dehydration?

That shows true mastery of the chronic care routine.

Okay, let's detail the critical therapeutic techniques.

Beginning with the definitive diagnostic procedure.

Bone marrow aspiration and biopsy or BMA.

BMA tells us precisely what is going on inside the factory.

Its purpose is to determine the cell type and quantity being produced.

Is the marrow depressed like in aplastic anemia?

Or is it hyperstimulated like in balacemia?

And the sites are different in kids?

Yes.

In children, the common sites are the iliac, crests, or spines.

They're preferred over the stunum because they're less psychologically frightening and they hold the largest marrow compartments.

For neonates, the anterior tibia is used.

The procedure is invasive.

It requires conscious sedation.

What are the nursing priorities immediately post procedure?

The child is often lying prone.

Local anesthesia is used, but they still feel a sharp sensation during the aspiration.

After removal, pressure is applied for 5 to 10 minutes, followed by a firm pressure dressing.

And the priority is?

Bleeding.

Period.

Our priority is monitoring for immediate bleeding.

We have to monitor vital signs, pulse, and BP, and observe the dressing every 15 minutes for the first hour.

Why such intense monitoring of BP?

The bone marrow is highly vascular.

A small bleed into the soft tissue, if it goes unrecognized, can rapidly lead to hypovolemia and shock in a child.

So you keep the child immobile for an hour.

Yes, and parents must also monitor for delayed signs of infection, specifically checking the temperature at 12 and 24 hours.

And therapeutic play post procedure is also important to help them process the fear.

Next up, the most common intervention.

Blood transfusion.

What product is typically preferred in pediatrics?

And what is the absolute golden rule of infusion?

We use packed RDCs most frequently.

They deliver the necessary oxygen carrying capacity while minimizing the volume, which reduces the risk of circulatory overload in a small child.

And golden rule.

Absolutely.

The blood product must be infused only with an isotonic solution, specifically normal saline.

And the reason for that saline only rule speaks directly back to our AMP.

It does.

If we mix blood with a hypertonic solution, the RDCs shrink.

If we use a hypertonic solution, the cells burst.

In either case, the cells are destroyed, and the transfusion is useless and potentially harmful.

And the volume is precise.

Very.

Typical volume is 15 millibels per kilogram, and the standard rate is 10 millibels per kilogram per hour, adjusted only for shock.

A key fact to remember, 10 millibels per kilogram of packed RDCs should raise the hematocrit by about five points.

Pre -transfusion care requires signed consent, always respecting those religious directives like for Jehovah's Witnesses, and monitoring is non -negotiable.

Baseline vitals are a must.

We start the rate slow for the first 15 minutes.

If there's no sign of reaction, we increase the rate.

Vitals continue to be monitored every 15 minutes for that first hour, the highest risk period, and then every 30 minutes afterward.

Let's drill down into the life -saving knowledge of transfusion reactions.

Let's focus on the timing and the immediate intervention, which is often a high -stakes moment for the nurse.

Okay.

The moment you suspect a reaction, your first move is to stop the transfusion immediately.

All right.

What if it's anaphylactic or hemolytic?

This is immediate, severe, potentially fatal.

Symptoms are pain at the IV site, dyspnea, hypotension, hemoglobinuria.

After stopping, you maintain the IV line with normal saline, administer oxygen, and anticipate meds like diuretics or heparin.

What about an allergic reaction?

That happens within the first hour.

The symptoms are milder, itching, or pruritus, hives, urticaria, or wheezing.

Stop the infusion, give oxygen, and anticipate an antihistamine.

Often you can resume the transfusion after that.

Bacterial contamination.

That generally appears around one hour, signaled by a sudden spike in temperature.

You stop the infusion and obtain a blood culture to identify the pathogen.

Triculatory overload.

This occurs during the course of the infusion from too much volume.

Symptoms are an increased pulse and dyspnea.

You stop the infusion, administer oxygen, and anticipate a diuretic to manage potential heart failure or edema.

Hypocalcemia.

This is a chemical reaction.

The citrate anticoagulant in the blood binds serum calcium.

Symptoms are muscle cramping, twitching, and potential seizures.

Stop the infusion and anticipate giving IV calcium gluconate.

And finally, hemocytosis.

This occurs after repeated transfusions.

It causes bronze -colored skin due to iron deposition.

The intervention here is long -term, administering iron -chelating agents.

Now let's discuss hematopoietic stem cell transplantation, or HSCT, the potential cure for many blood dyscretias.

Right.

HSCT involves infusing healthy stem cells to replace deficient or non -functioning bone marrow in conditions like aplastic anemia, sickle cell, or thalassemia.

It offers the only potential for a complete permanent reversal of the disease.

And we have three types based on the source.

Allogeneic uses an immune -compatible HLA -matched donor, ideally a sibling or a national bank match.

Syngeneic is the rarest, using an identical twin.

An autologous uses the child's own cells, often cord blood banked at birth, or cells harvested and treated before reinfusion.

The preparation for the recipient is intense.

It's basically total body immunosuppression.

It is an ordeal.

To ensure the host body doesn't reject the graft, the child gets total body irradiation or powerful immunosuppressive drugs like cyclophosphamide to destroy their existing marrow.

This comes with extreme side effects.

Severe nausea, vomiting, diarrhea.

It requires intensive management.

The infusion itself has a unique nursing rule.

It does.

The donor marrow is aspirated, strained, and infused IV over 60 to 90 minutes.

And here is the critical procedural point.

You must not use a standard blood product filter.

Why not?

The filter would actually remove the marrow tissue itself, which would render the procedure completely ineffective.

Wow, okay.

Post -infusion, we monitor cardiac rate and rhythm closely, looking for signs of circulatory overload or potential pulmonary emboli from the unfiltered particles.

Post -infusion care is defined by a rigorous focus on infection control while waiting for engraftment.

Absolutely.

Fever and chills are common, treated symptomatically, but strict monitoring is paramount.

Temperature checks every four hours.

The diet is severely limited to cooked foods only.

We avoid unwashed produce, though thick -skinned fruits that can be peeled are often allowed.

And the wait for engraftment is agonizing for the family.

It really is.

Engraftment is successful when new RBCs appear in the peripheral blood, which is typically in about three weeks.

But the full recovery of WBC and platelet counts can take up to a full year.

That long isolation period must fuel intense anxiety.

For everyone.

The recipient, the donor.

The nursing team has to provide reassurance that the outcome is immunologic.

It's not based on personal factors.

And then there's the high risk of graft -versus -host disease, GVHD.

GVHD is a lethal potential outcome where the donor's T cells attack the recipient's tissues.

Symptoms can range from a mild rash and fever up to life -threatening diarrhea and organ enlargement.

Prevention is key.

Perfect tissue typing, pre -transplant corticosteroids, and irradiation of all blood products the child receives.

The final technique we should cover is splenectomy, which is commonly performed when the spleen is overworking.

Right.

In diseases like sickle cell and thalassemia, the spleen aggressively destroys the abnormal, short -lived RBCs.

This leads to chronic, severe anemia, with HGB often between 5 and 9 GLL.

So removing the spleen helps.

Removing the spleen stops this massive destruction, which reduces the need for transfusions.

But, and this is a big but done, it doesn't cure the underlying cell defect.

And the risk shifts to infection.

Precisely.

The spleen usually filters encapsulated microorganisms.

Without it, the child is highly susceptible to pneumococcal and other bacterial infections.

Post -splenectomy care requires two critical steps.

Prophylactic oral penicillin for one to two years, and ensuring the child is current on all relevant vaccines, especially meningococcal.

Parents have to be educated to report any signs of infection immediately.

Okay, let's delve into the specific disorders now.

Anemias, a reduction in number or function, are generally symptomatic when HGB drops to about 7 or 8 grams per 100 ml.

We classify them by cell appearance and source.

Right.

We begin with normochromic, normacytic anemias.

So, normal color and size, but a low count.

This suggests either impaired production or an acute loss.

Starting with acute blood loss anemia.

This results from trauma, nephritis, or parasitic loss.

The symptoms are classic.

Pallor, tachycardia, and rapid breathing, or tachypnea.

The key clinical insight here is that these children will show a poor response to oxygen therapy.

Why is that?

Because the core problem is a lack of RBC carriers, not lung function.

So, management is immediate.

Control the bleeding, lay the child flat, keep them warm, and infuse RBCs or blood expanders like saline.

It's a transient condition, and you'll see a rising reticulocyte count as they recover.

Other anemias in this category include anemia of acute infection.

Which is resolved by treating the underlying cause like osteomyelitis.

Anemia of renal disease.

Resolved with recombinant human erythropoietin.

And anemia of neoplastic disease.

Right, where the bone marrow is invaded by cancer cells, it's resolved by achieving remission.

We also have hypersplenism, where an overactive spleen causes pancytopenia, a deficiency of all cell elements.

This might require a splenectomy.

Now for the severe category.

The plastic anemias, where all cell lines are affected because of bone marrow depression.

This is critical.

The congenital form is Fanconi syndrome.

It's autosomal recessive and associated with skeletal and renal anomalies, typically leading to bone marrow failure within the first decade of life.

And the acquired form.

It's often triggered by environmental exposure.

Radiation, toxic drugs like chloramphenicol or insecticides.

It can also follow a severe infection due to autoimmune suppression of the marrow.

The assessment findings reflect the failure of all three lines.

RBCs, WBCs and platelets.

Exactly.

You get pallor and fatigue from the low RBCs, increased infections from the low WBCs or neutropenia.

But most distinctly, thrombocytopenia leads to easy bruising, petechia, and excessive bleeding like GI bleeds and nosebleeds.

A BMA will show reduced elements infiltrated by fatty tissue.

Management is focused on definitive cure or supportive care.

The ultimate therapy is HSCT.

If there's no donor, management includes transfusions of RBCs and platelets, powerful immunosuppressants like cyclosporine or ATG, which requires anaphylaxis monitoring, or steroids like prednisone.

Testosterone might be used to stimulate RBC growth, but it has significant side effects.

Because thrombocytopenia presents a constant danger, the nursing care planning for reducing bleeding risk, which is box 44 .3, is essential practical knowledge for every nurse.

This is all about hands -on protection.

We limit blood draws and consolidate samples, we use a BP cuff instead of a tourniquet for less pressure, and we apply pressure to any puncture site for a full five minutes.

And we minimize tape, pad the rails.

Right.

We minimize adhesive tape, pad, crib, and side rails, and protect IV sites.

And the education for home care is meticulous.

It has to be.

The child must use a soft toothbrush and avoid high -impact activity.

We substitute IM or SQ injections with oral or IV medications.

The goal is to encourage quiet, engaging activities rather than rough play to minimize the risk of accidental hemorrhage.

This level of long -term medical management also introduces a significant psychosocial challenge, particularly regarding body image.

Oh, definitely.

Since these treatments last for years, we have to address the altered body image risk.

For instance, corticosteroids cause a Cushingoid appearance, hirsutism, weight gain.

Testosterone causes masculinizing effects.

So the nurse's role is reassurance.

Reassurance and support.

Clarifying to both the child and the parents that these physical changes are temporary and will resolve once the medication is stopped.

It helps the family maintain a sense of normalcy and self -esteem.

Okay, shifting to hypoplastic anemias.

Where only the RBC line is depressed.

The congenital form, Diamond Black Fan, is rare, showing symptoms around 6 to 8 months.

The acquired form is often transient, sometimes caused by Parvovirus B19.

An assessment is tricky.

It is, because the insidious onset mimics iron deficiency.

However, the crucial lab difference is that hypoplastic cells are normochromic and normacitic, unlike the pale small cells of iron deficiency.

For the congenital form, frequent transfusions are often needed, which introduces the necessity of iron chelation.

Yes.

When a child gets frequent transfusions, the body accumulates excess iron hemocytosis, which damages the heart, pancreas, and liver.

Chelation is vital.

How does it work?

Agents like deferoxamin, which is a subcutaneous infusion nightly, or oral defroserox, they bind the iron so it can be excreted, primarily in the urine.

So parents have to monitor urine output and specific gravity.

We also advise on slit -lamp eye exams, as deferoxamin carries a risk of cataracts.

Our final category here, hypochromic anemias.

Pale colors, small size, or microcytic due to inadequate hemoglobin production.

The standout is iron deficiency anemia.

This is the most common anemia of childhood, and it stems from diet.

It peaks between 9 months and 3 years.

Too much milk, not enough iron -rich food, and again during adolescence from low meat intake or menstruation.

And preterm infants are also at high risk.

Right, because they miss out on that final trimester of maternal iron reserves.

The classic physical signs and the fascinating CNS length should be highlighted here.

Okay, signs include pale conjunctiva, poor muscle tone, and the classic spoon -shaped nails, colonicchia.

In the lab, Hgb is low, and the cells are microcytic and hypochromic.

And the CNS length?

Here's the key synthesis point.

Iron is a component of monoamine oxidase, MAO, which is essential for CNS maturation.

Therefore, iron deficiency is linked to poor school achievement, and is often associated with pica -creving us or inedible materials.

The treatment is ferrous sulfate, but the nursing implications of administration are vital to prevent harm.

Right.

To maximize absorption, it's best given on an empty stomach with water.

But after meals, if it causes GI upset, avoid giving it with milk or tea.

And the concept mastery alert is crucial.

It is.

If you're using the liquid form, mix it with juice, administer it through a straw, and the child must brush their teeth thoroughly afterward, ferrous sulfate will permanently stain teeth.

We also advise parents about the side effects, dark stools and constipation, and encourage fiber and vitamin C to enhance absorption.

Now for the hemolytic anemias, the destruction of RBCs.

This includes some of the most complex chronic conditions we treat.

Starting with congenital spherocytosis.

This is an autosomal dominant condition where the RBC membrane protein is faulty, making the cell small and structurally weak.

The spleen recognizes them as abnormal and aggressively destroys them.

Leading to severe anemia.

Severe anemia, chronic jaundice, and splenomegaly.

Management is often surgical.

Yes.

Transfusions manage the acute crises.

The treatment is a splenectomy, typically done at five to six years old.

This reduces the anemia severity by stopping the destruction, but the cells themselves remain structurally abnormal.

Older children might need their gallbladder removed because the continuous release of bilirubin can cause gallstones.

Next, glucose -6 -phosphate dehydrogenase deficiency, or G6PD, an X -linked recessive condition common in specific global populations.

A lack of this enzyme means the RBCs are highly susceptible to oxidation, leading to premature destruction.

It presents in two forms.

A chronic congenital type, or more commonly, a drug -induced form where the blood pattern is normal until a trigger is introduced.

What are the primary triggers nurses most educate families about?

Fava beans and key oxidant drugs,

including acetylsalicylic acid, or aspirin, sulfonamides, and anti -malarials.

Hemolysis starts about two days after ingestion.

For the drug -induced type, the primary management is simple.

Avoidance of these triggers.

So patient education is paramount.

On reading over -the -counter drug labels?

Yes, absolutely.

Now, the profound chronic condition,

sickle cell anemia, SCA.

We have to connect this back to our seven -year -old case study.

SCA is autosomal recessive, a defect in the beta chain that causes hemoglobin S.

Under conditions of low oxygen tension, low pH, or dehydration, the RBCs contort into a sickled crescent shape.

The sickling causes stasis, ischemia, acute pain, and rapid cell destruction.

And this condition is silent until the six -month mark when HGBF is replaced.

So what triggers the sudden severe onset of a vaso -occlusive crisis?

Triggers include GI illness, which leads to dehydration, a respiratory infection leading to hypoxia, or even extreme physical exertion.

The resulting tissue hypoxia and ischemia cause that sudden severe pain that defines the crisis.

And there are other types of crises.

Yes.

There's a sequestration crisis, which is pooling in the spleen or liver that leads to hypovolemic shock.

And in a plastic crisis, a temporary cessation of production, often due to an infection.

The assessment findings are vast because it's a multi -systemic disorder.

The child often has yellow sclera, generalized pain, and chronic changes like a thin build, long limbs, and delayed puberty.

In infants, we see hand -foot syndrome, painful swollen hands and feet.

And chronically.

Repeated infarcts lead to splenic atrophy in adolescents, making them profoundly infection -prone.

Long -term complications include acute chest syndrome, CVA, decreased vision, and kidney dysfunction.

Therapeutic management during a crisis focuses on that critical triad.

Pain, hydration, and oxygenation.

Right.

Pain relief has to be aggressive, ranging from scheduled oral analgesics to IV morphine.

Hydration is achieved with intensive IV fluids to reduce the blood viscosity and prevent further sickling.

And oxygenation is given to halt the sickling process, but cautiously.

You also correct acidosis.

Yes.

Withholding potassium until renal function is confirmed.

Transfusion is reserved for life -threatening complications.

Long -term, the nurse has to monitor treatment with hydroxyurea.

Hydroxyurea is a critical antineoplastic drug that strengthens the sickled cells and increases their oxygen capacity.

A key nursing consideration is monitoring the white lead cell count, as a side effect is lowered WBCs, which increases infection risk.

HSCT remains the permanent cure option.

The interprofessional care map in box 44 .8 highlights the QSEN competencies in managing a crisis.

It does.

Teamwork is emphasized through required hematology consultation and continuous monitoring.

Patient -centered care dictates aggressive pain assessment, using something like the FASAS scale and strict bed rest to reduce oxygen demand.

And the core of that is family education.

Absolutely.

Education on avoiding the two major triggers, dehydration and oxygen deficiency.

Let's elaborate on health maintenance between crises, especially the teaching points in box 44 .9.

This is the key to prevention.

Okay.

We teach parents to avoid supplementary iron.

As the child is already at risk for hemoseterosis from transfusions.

Folic acid is prescribed to support rapid RBC rebuilding, and immunizations must be comprehensive.

Pneumococcal, meningococcal, Hib, plus prophylactic penicillin to guard against encapsulated bacteria due to that splenic damage.

And the specific activity restrictions require careful explanation.

Yes.

Normal school and activity are encouraged.

But contact sports and long distance running are restricted due to the risk of splenic or liver rupture and dehydration, respectively.

Critically, we have to address the what if scenario.

The one about bedwetting.

Right.

Parents often restrict fluids after 4 PM to prevent bedwetting.

Nurses have to caution against this, emphasizing that dehydration is a major sickling trigger that outweighs the bedwetting issue.

Next, thalassemias, abnormalities of the beta chain leading to defective HDBA.

Thalassemia minor is the heterozygous form.

It's a mild asymptomatic condition.

The nurse must know this group should never receive routine iron supplements because they're at risk of iron accumulation even without transfusions.

And thalassemia major, coulianemia, the homozygous severe form, affects our 4 -year -old case study.

Symptoms appear once HGVF is replaced.

This is a life -altering disease.

HGV levels fall below 5 grams per 100 milligal.

The body's desperate compensatory hyperstimulation of the bone marrow leads to severe bone changes, which are detailed in Table 44 .3.

The physical changes are dramatic.

They are.

The parietal and frontal bossing, the prominent upper teeth, the flattened nose, this is the physical cost of chronic anemia, caused by bone marrow overgrowth in the face and skull.

We also see hemocytosis, causing bronze skin, leading to diabetes, cirrhosis, and heart failure from iron overload.

Management centers on hypertransfusion insulation?

Yes.

Hypertransfusion with packed RBCs every 2 to 4 weeks maintains HGV at 10 to 12 G 100 millilow.

This is high enough to suppress the bone marrow and minimize those deforming bone changes, delaying the need for a splenectomy.

And chelation is essential.

Essential to manage the resulting iron overload.

Prognosis is improving with HSCT, but without it, the risk of cardiac failure in adolescence is high.

The nursing care for thalassemia major must deeply address the psychosocial impact of these permanent changes.

It has to.

We focus on minimizing the risk of situational low self -esteem.

Nurses must allow for maximal peer interaction and school attendance.

It requires continuous conversation and support for the child dealing with delayed growth, delayed sexual maturation, and the visible permanent facial changes, helping them navigate peer reactions.

Finally, we cover autoimmune acquired hemolytic anemia.

This is antibody mediated destruction of RBCs, often triggered by viral infections, malignancies, collagen diseases, or certain drugs.

Assessment shows an insidious onset.

Fever, lethargy, pallor, jaundice.

Diagnosis is confirmed by a positive direct Coombs test, which shows antibodies on the RBCs.

And treatment is complicated.

It is.

Transfusion is difficult because of the blood clumping.

Treatment often involves corticosteroid therapy, like prednisone, to suppress the immune response.

If that fails, splenectomy or stronger immunosuppressants are used.

Parents need significant emotional support as they cope with the mystery of their child's body attacking itself.

Let's briefly address polysathemia, which is the opposite of anemia to many RBCs.

This is generally a compensatory response to chronic insufficient oxygenation, like in chronic pulmonary disease or congenital heart disease.

The body is attempting to carry more oxygen by making more cells.

The physical manifestation is very distinct.

The child exhibits plethora marked reddened appearance due to the sheer volume of RBCs.

The major danger is that the high cell count increases blood viscosity, raising the risk of CVA or embolay, which is compounded by dehydration.

So treatment focuses on the underlying cause.

Right, and sometimes phlebotomy or an exchange transfusion is needed to reduce the count.

Moving now to disorders of blood coagulation, starting with perporis, where the platelet count drops below 40 ,000 per cubic millimeter, or thrombocytopenia, causing bleeding into the skin.

The most common is idiopathic thrombocytopenic perpora, ITP.

It's an autoimmune disorder causing increased platelet destruction, often following a viral infection.

Symptoms are petechia and asymmetric bruising, with platelet counts often severely low.

Management is focused on immune modulation and safety.

Exactly.

We use oral prognosone, IVG, or anti -D immunoglobulin.

And critically, for pain relief, we use acetaminophen and strictly avoid salicylates and ibuprofen, which interfere with platelet function and increase bleeding risk.

The QSEN safety priority for ITP patients is the single most important alert for the nurse.

Intracranial hemorrhage is the highest risk.

Nurses have to be hypervigilant and educate parents immediately on recognizing the signs.

A persistent headache with vomiting, lethargy, slurred speech, or new seizures.

Parents must be terrified.

They often fear the symptoms mimic leukemia, so clear education is vital for managing their anxiety.

This is a hypersensitivity reaction causing bleeding into small vessels, often after a mild infection.

The hallmark is a distinctive purpura rash on the buttocks, thighs, and extensor surfaces.

Unlike ITP, the platelet count is normal.

They often have painful swollen joints and abdominal pain, but the primary concern is kidney involvement, signaled by hematuria.

Management involves oral corticosteroids and mild analgesics.

Nurses have to continuously assess urine for protein and glucose as the risk of chronic nephritis is significant.

Finally, the hemophilias inherited factor deficiencies.

We start with hemophilia A, classic hemophilia, a factor 8 deficiency.

This is sex -linked recessive, affecting males, and it impairs the intrinsic coagulation pathway.

Bleeding eventually stops because of the intact extrinsic pathway, but it's significantly delayed.

And assessment.

Severe bruising and classically painful hemorrhage into the joint semarthrosis, which leads to irreversible joint damage and loss of mobility.

Management requires immediate factor 8 replacement.

It does.

Diagnosis is made by a prolonged PTT.

Management involves immediate replacement, ideally using concentrated factor 8 product available for home use.

Desmopressin, or DDAVP, can also stimulate factor 8 release.

Parental education on injury prevention is foundational to their long -term care.

The focus is proactive safety, padding cribs, using soft toys, and encouraging low -impact daily activity to prevent obesity, which stresses the joints.

Parents are taught to administer the replacement factor 4V immediately after an injury, combined with pressure, immobilization, and ice.

What about pain management?

For joint bleeds, we use acetaminophen, avoiding ibuprofen.

We immobilize the joint and begin passive range of motion about 48 hours after the acute bleed resolves.

The source also mentions von Willebrand disease and Christmas disease.

Right.

Von Willebrand disease is autosomal dominant, affecting both sexes.

It involves a factor 8 defect and poor platelet function, resulting in prolonged bleeding time, often from mucous membranes.

Christmas disease, or hemophilia B, is a factor IX deficiency, treated with factor IX concentrate.

And we must also briefly note disseminated intravascular coagulation,

DIC.

This is an acquired disorder from overwhelming trauma or infection, leading to uncontrolled consumption of clotting factors.

It causes simultaneous bleeding from IVs and injection sites and petechiae, requiring critical observation in seriously ill children.

That concludes our intensive synthesis of pediatric hematologic disorders.

We've streamlined the AMP and amplified the clinical and psychosocial care needed for these children.

Let's recap the five key actionable takeaways for our nursing students.

First, remember the fundamental developmental shift.

The HDB -F'd to HDBA transition at six months is why beta -chain diseases like sickle cell and thalassemia manifest clinically only after that age.

Second, the core therapeutic challenge for chronic diseases is iron overload, hemosyterosis, which demands consistent iron chelation therapy for any patient receiving frequent transfusions.

Third, for a sickle cell crisis, nursing intervention relies on the core triad, aggressive pain relief, intensive hydration, and careful oxygenation.

And education on avoiding dehydration is the single most important preventive measure.

Fourth, when you're managing a child with low platelets like an ITP, the absolute priority is the risk of intracranial hemorrhage, requiring constant monitoring for neurological changes.

And fifth,

managing these chronic conditions requires continuous holistic support.

You have to ensure that adherence, family coping, and body image concerns like bone bossing and thalassemia or medication side effects are integrated into the care plan to ensure developmental success.

We began by meeting the parents of the 12 -year -old sickle cell patient, who, struggling with his grades and the uncertainty of his prognosis, asks, if I don't get a transplant, does it matter what my grades are?

And that just highlights the profound existential dilemma of chronic illness.

We teach families and children to enforce strict medical adherence and protective measures, avoiding contact sports, enduring painful procedures, swallowing bitter medicine, all aimed at maximizing physical longevity.

But those protections often clash with the child's profound need for age -appropriate psychological freedom, for peer engagement, and the self -worth that comes from school, sports, and just normal social interaction.

So, the provocative thought we leave you with is this.

In the chronic care of a child with an uncertain prognosis, how do you, as the nurse, counsel a family to ethically balance the medical necessity of enforcing protective limits, limits that maximize lifespan against the child's psychological necessity for self -determination and the emotional freedom that defines a life well -lived, regardless of its length?

It's a question that reminds us that we are treating the child and the family, not just the blood counts.

Thank you for joining us on this deep dive.

Be well and keep learning.